{
  "docId": "019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "docSlug": "c76f9a1cfbf11e27618f62d901587aa3",
  "documentTitle": "Alkermes | Results Presentation Deck | 22 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 22,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a bulleted list format with circular icons to emphasize three key benefits of the proposed business separation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-e60e-740c-a4d1-b8dd6fcd421d/6",
  "deckHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "deckJsonHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d.json",
  "deckAnchorHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d#slide-6",
  "components": [
    {
      "bbox": {
        "x": 0.28,
        "y": 0.28
      },
      "kind": "list",
      "text": "Drive a sharp strategic focus with distinct management teams with relevant therapeutic expertise; Simplify capital allocation decision-making and increase flexibility; Enable capital markets to better assess value, performance and potential, and attract a long-term shareholder base suited to each business",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8358251c-931d-46bc-8120-f494e34a0549",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.05,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "Separation of the oncology business expected to drive benefits for both neuroscience and oncology businesses",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c647335-1568-4415-922a-9c2924ee4799",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Exploring Separation of Oncology Business as Part of Ongoing Board-Level Review of Strategic Alternatives",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a0a66e2-964c-4e4f-b3ee-8b665b7f3008",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "breakup-spinoff",
      "slug": null,
      "matchId": "cf6aaff2-abba-4bcf-a930-b7e02de4362f",
      "evidence": "The slide discusses the strategic rationale for separating a business unit (oncology) from the parent company.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 6,
      "beatId": "447f6264-8955-4168-914e-cfe1363597e7",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document proposes a solution (separation of oncology business) and presents expected outcomes to satisfy the audience's needs.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 6,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "a5a157cc-9029-478a-92e9-6838ab291f2a",
      "evidence": "The document presents a clear pattern of benefits, including enhanced profitability and clear value propositions.",
      "position": 0,
      "objective": "What are the benefits of separating the oncology business?",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}